Northern Trust Company of Connecticut’s Biogen BIIB Stock Holding History

Northern Trust Company of Connecticut’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$77.5M	Sell	277,138 -16,922	-6%	-$4.38M	0.49%	20
2013 Q3	$70.8M	Buy	294,060 +5,970	+2%	+$1.34M	0.46%	21
2013 Q2	$62M	Buy	+288,090	New	+$61.6M	0.42%	27

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Northern Trust Company of Connecticut's BIIB Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Biogen (BIIB) stake by 5.8% in Q4 2013, selling an estimated $4.38M and leaving 277,138 shares worth $77.5M. The position accounts for 0.49% of the portfolio, ranked #20.

Northern Trust Company of Connecticut first reported a position in BIIB in Q2 2013 and has held it in 3 quarters since. 739 funds tracked by Wall St. Rank hold BIIB as of Q4 2013.

Northern Trust Company of Connecticut held 277,138 shares of Biogen worth $77.5M as of Q4 2013.
Northern Trust Company of Connecticut sold 16,922 Biogen shares in Q4 2013, an estimated $4.38M.
Biogen made up 0.49% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #20 holding.
Northern Trust Company of Connecticut first reported a position in Biogen in Q2 2013 and has held it in 3 quarters since.
739 funds tracked by Wall St. Rank held Biogen as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.